A derivative of lycorine with antihypertensive and neuroprotective activities
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Dihydrolycorine

Item No. 27809

Technical Information
Formal Name
(1S,2S,3aR,12bS,12cR)-2,3,3a,4,5,7,12b,12c-octahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol
CAS Number
6271-21-2
Molecular Formula
C16H19NO4
Formula Weight
Purity
≥98%
A solid
DMSO: 3mg/mLPBS (pH 7.2): 2.5mg/mL
λmax
242, 290 nm
SMILES
O[C@@H]1[C@@H](O)C[C@]2([H])[C@@]3([H])N(CC2)CC4=CC5=C(OCO5)C=C4[C@@]31[H]
InChi Code
InChI=1S/C16H19NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h4-5,8,11,14-16,18-19H,1-3,6-7H2/t8-,11+,14+,15-,16-/m1/s1
InChi Key
VJILFEGOWCJNIK-MGRBZGILSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Dihydrolycorine is a derivative of the alkaloid lycorine that has antihypertensive and neuroprotective activities.1 It inhibits methoxamine-induced contraction of isolated rabbit aortic rings and rat anococcygeus muscle with pA2 values of 5.93 and 6.35, respectively. Dihydrolycorine reduces mean arterial pressure (MAP) in anesthetized and conscious normotensive rats when administered at a dose of 80 mg/kg. It also reduces electrically or phenylephrine-induced hypertension in pithed rats. Dihydrolycorine reduces infarct size, cerebral edema, and myeloperoxidase activity in a rat model of focal cerebral ischemia-reperfusion injury when administered following reperfusion.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chen, B.Y., Du, Z.H., Zeng, F.D., et alHypotensive effect of dihydrolycorine. Zhongguo Yao Li Xue Bao 14(1), 45-49 (1993).

    2. Jiang, S., Yu, G., Yu, L., et alTherapeutic effect of dihydrolycorine on focal cerebral ischemia-reperfusion injury in rats. Yunyang Yixueyuan Xuebao 28(5), 453-456 (2009).